An observational study in Melanoma (Skin Cancer), sponsored by The Christie NHS Foundation Trust. Not yet recruiting at 1 site in United Kingdom. Per ClinicalTrials.gov, last updated 2025-12-19.
Sponsored by The Christie NHS Foundation Trust · Observational
This study is a retrospective, proof-of-concept sample study to investigate a novel histological finding within the primary melanoma tumour in a large population of melanoma patients to assess its prognostic significance.
This is a aims to validate the striking observation that a cross-talk between fat cells and leukocytes at the primary melanoma site promotes metastasis. In our unpublished pilot study, we have discovered an interesting finding whereby inflammatory cells extend from the tumour to and invading fat in the subcutaneous tissue and/or around the appendageal structures in the dermal skin in metastatic melanomas with distinct architectural changes within the fat. This finding was consistently present in metastatic and absent in non-metastatic melanomas. This new finding has both clinical and pathophysiological credence. Archival tissue blocks or human cell lines will be used in the first instance. As mitigation, experiments will be repeated with conditioned media obtained from co-culture of mixed primary immune cells obtained from peripheral blood mononuclear cell (PBMCs) and adipocytes induced from stem cells.
This study aims to:
The patients have not provided consent and will be justified in this application
3,006 studies on the registry are indexed under Melanoma; 520 are open to participants now.
This study's planned enrollment of 20 is below the median of 182 across 438 observational studies indexed under Melanoma.
Browse Melanoma studies →The Christie NHS Foundation Trust is the lead sponsor of 99 studies on the registry; 25 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Sample analysis of melanoma only
Review of histological slides for presence or absence of relevant histological features.
For group 3 and group 4:
Exclusion Criteria:
Sample analysis only
What is the predictive accuracy of inflammatory cell invasion into the subcutaneous fat layer in primary melanoma for determining the risk of metastasis and/or disease progression?
Time frame: 1 year
Plan to share: Undecided
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Christie NHS Foundation Trust